Format

Send to

Choose Destination
Circulation. 2018 Nov 10:CIR0000000000000625. doi: 10.1161/CIR.0000000000000625. [Epub ahead of print]

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol.

Author information

1
ACC/AHA Representative.
2
AACVPR Representative.
3
ACC/AHA Task Force on Clinical Practice Guidelines Liaison.
4
Prevention Subcommittee Liaison.
5
PCNA Representative.
6
AAPA Representative.
7
AGS Representative.
8
ADA Representative.
9
PM Representative.
10
ACPM Representative.
11
NLA Representative.
12
APhA Representative.
13
ASPC Representative.
14
ABC Representative.

KEYWORDS:

AHA Scientific Statements; Guidelines; biomarkers, coronary artery calcium score; cardiovascular disease; cholesterol, LDL-cholesterol; diabetes mellitus; drug therapy; ezetimibe; hydroxymethylglutaryl-CoA reductase inhibitors/statins; hypercholesterolemia; lipids; patient compliance; pharmacological; primary prevention; proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors; risk assessment; risk reduction discussion; risk treatment discussion, secondary prevention

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center